In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 30th, 2005 | 23 | No |
Popular Name: SU-6668 SU-6668
Find On: PubMed — Wikipedia — Google
CAS Numbers: 210644-62-5 , 210644-62-5; 245036-27-5; 252916-29-3 , 245036-27-5 , 252916-29-3 , [252916-29-3]
(Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.75 | -0.54 | -52.99 | 2 | 5 | -1 | 88 | 309.345 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 97% | Fluorochem |
Target | VEGFR, PDGFR , FGFR | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 35 | 0.45 | Binding ≤ 10μM |
AURKC-1-E | Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic | Eukaryotes | 210 | 0.41 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3040 | 0.34 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 60 | 0.44 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2000 | 0.35 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 680 | 0.38 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9300 | 0.31 | Functional ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9500 | 0.31 | Functional ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9500 | 0.31 | Functional ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 410 | 0.39 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 100 | 0.43 | Binding ≤ 1μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 35 | 0.45 | Binding ≤ 1μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 210 | 0.41 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 680 | 0.38 | Binding ≤ 1μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 1810 | 0.35 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 100 | 0.43 | Binding ≤ 10μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 35 | 0.45 | Binding ≤ 10μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 210 | 0.41 | Binding ≤ 10μM |
VGFR1_MOUSE | P35969 | Vascular Endothelial Growth Factor Receptor 1, Mouse | 2000 | 0.35 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 2400 | 0.34 | Binding ≤ 10μM |
VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 2000 | 0.35 | Binding ≤ 10μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 9300 | 0.31 | Functional ≤ 10μM |
PGFRA_MOUSE | P26618 | Platelet-derived Growth Factor Receptor Alpha, Mouse | 1000 | 0.37 | Functional ≤ 10μM |
PGFRB_MOUSE | P05622 | Platelet-derived Growth Factor Receptor Beta, Mouse | 1000 | 0.37 | Functional ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 410 | 0.39 | Functional ≤ 10μM |
Description | Species |
---|---|
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
Constitutive PI3K/AKT Signaling in Cancer | |
Downstream signal transduction | |
EPHA-mediated growth cone collapse | |
Integrin cell surface interactions | |
Mitotic Prometaphase | |
Neurophilin interactions with VEGF and VEGFR | |
PIP3 activates AKT signaling | |
Resolution of Sister Chromatid Cohesion | |
Separation of Sister Chromatids | |
Signaling by activated point mutants of FGFR1 | |
Signaling by FGFR mutants | |
Signaling by PDGF | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |